Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gaudet

Showing results (111-120 of 296) with videos related to

Pageof 30
Sort By:
Journal of Applied Toxicology : JAT|November 5, 1999
Phase III interlaboratory study of FETAX. Part 3. FETAX validation using 12 compounds with and without an exogenous metabolic activation systemJ A Bantle, R A Finch, D J Fort, et al.
International Journal of Cancer|October 25, 2011
A prospective investigation of coffee drinking and endometrial cancer incidenceMarc J Gunter, Jennifer A Schaub, Xiaonan Xue, et al.
CA: a Cancer Journal for Clinicians|October 3, 2019
Breast cancer statistics, 2019Carol E DeSantis, Jiemin Ma, Mia M Gaudet, et al.
Breast Cancer Research and Treatment|July 3, 2019
Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-IISamantha Puvanesarajah, Susan M Gapstur, Alpa V Patel, et al.
ACS Applied Nano Materials|November 9, 2020
Complex Relationship Between Iron Oxide Nanoparticle Degradation and Signal Intensity in Magnetic Particle ImagingJulia Guzy, Shatadru Chakravarty, Foster J Buchanan, et al.
Scientific Reports|January 14, 2018
<sup>19</sup>F-perfluorocarbon-labeled human peripheral blood mononuclear cells can be detected in vivo using clinical MRI parameters in a therapeutic cell settingCorby Fink, Jeffrey M Gaudet, Matthew S Fox, et al.
Breast Cancer Research and Treatment|November 4, 2009
Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2S M Domchek, M M Gaudet, J E Stopfer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2012
Weight cycling and risk of endometrial cancerVictoria L Stevens, Eric J Jacobs, Juzhong Sun, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 24, 2019
Time to Diagnosis and Treatment with Palliative Radiotherapy among Inuit Patients with Cancer from the Arctic Territory of Nunavut, CanadaJ Chan, K Linden, C McGrath, et al.
International Journal of Molecular Epidemiology and Genetics|September 19, 2013
Obesity-related markers and breast cancer in CPS-II Nutrition CohortMia M Gaudet, Alpa V Patel, Lauren R Teras, et al.
Pageof 30

Showing results (111-120 of 296) with videos related to

Sort By:
Pageof 30
Journal of Applied Toxicology : JAT|November 5, 1999
Phase III interlaboratory study of FETAX. Part 3. FETAX validation using 12 compounds with and without an exogenous metabolic activation systemJ A Bantle, R A Finch, D J Fort, et al.
International Journal of Cancer|October 25, 2011
A prospective investigation of coffee drinking and endometrial cancer incidenceMarc J Gunter, Jennifer A Schaub, Xiaonan Xue, et al.
CA: a Cancer Journal for Clinicians|October 3, 2019
Breast cancer statistics, 2019Carol E DeSantis, Jiemin Ma, Mia M Gaudet, et al.
Breast Cancer Research and Treatment|July 3, 2019
Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-IISamantha Puvanesarajah, Susan M Gapstur, Alpa V Patel, et al.
ACS Applied Nano Materials|November 9, 2020
Complex Relationship Between Iron Oxide Nanoparticle Degradation and Signal Intensity in Magnetic Particle ImagingJulia Guzy, Shatadru Chakravarty, Foster J Buchanan, et al.
Scientific Reports|January 14, 2018
<sup>19</sup>F-perfluorocarbon-labeled human peripheral blood mononuclear cells can be detected in vivo using clinical MRI parameters in a therapeutic cell settingCorby Fink, Jeffrey M Gaudet, Matthew S Fox, et al.
Breast Cancer Research and Treatment|November 4, 2009
Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2S M Domchek, M M Gaudet, J E Stopfer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2012
Weight cycling and risk of endometrial cancerVictoria L Stevens, Eric J Jacobs, Juzhong Sun, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 24, 2019
Time to Diagnosis and Treatment with Palliative Radiotherapy among Inuit Patients with Cancer from the Arctic Territory of Nunavut, CanadaJ Chan, K Linden, C McGrath, et al.
International Journal of Molecular Epidemiology and Genetics|September 19, 2013
Obesity-related markers and breast cancer in CPS-II Nutrition CohortMia M Gaudet, Alpa V Patel, Lauren R Teras, et al.
Pageof 30